Chronic Lymphocytic Leukemia
We recommend
Sequential administration of immunochemotherapy and venetoclax after failure of BCR inhibitor treatment – interactive video case study
The treatment of chronic lymphocytic leukemia (CLL) is evolving. What was impossible years ago is now becoming a reality. From chemotherapy, through immunochemotherapy, to the use of molecules targeting apoptotic pathways of tumor cells, the prognosis for patients has markedly improved. However, the wide therapeutic spectrum also brings its own specifics and complications, and the correct sequencing of treatment lines and their selection for each individual is necessary, considering the nature of CLL, overall condition, and comorbidities.
Seventy-day Shedding of SARS-CoV-2 in an Immunocompromised Patient with CLL – A Case Study
A team of American and British experts published the case of a 71-year-old woman with chronic…
No content is currently available on this topic.
Subscribe
E-courses on this topic
Conferences news
Go to records
Go to records
Go to records
Go to records
Go to records
Go to records
Most read on this topic
- Sequential administration of immunochemotherapy and venetoclax after failure of BCR inhibitor treatment – interactive video case study
- Seventy-day Shedding of SARS-CoV-2 in an Immunocompromised Patient with CLL – A Case Study
Journal on this topic
Related topic